On the reproducibility of results of pathway analysis in genome-wide expression studies of colorectal cancers

Journal of Biomedical Informatics

Volumn 43, Issue 3, 2010, Pages 397-406

  Maglietta, Rosalia ^a   Distaso, Angela ^a   Piepoli, Ada ^b   Palumbo, Orazio ^b   Carella, Massimo ^b   D'Addabbo, Annarita ^a   Mukherjee, Sayan ^c   Ancona, Nicola ^a  

^a INSTITUTE OF INTELLIGENT SYSTEMS FOR AUTOMATION   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c DUKE UNIVERSITY   (United States)

Author keywords

Bioinformatics; Colorectal cancer; Microarray data; Pathway

Indexed keywords

BIOLOGICAL PROCESS; COLORECTAL CANCER; DATA SETS; GENE EXPRESSION DATA; GENE NETWORKS; GENE SETS; GENOMICS; MICROARRAY DATA; PATHWAY ANALYSIS; REPRODUCIBILITIES; STATISTICAL MODELS; STATISTICAL SIGNIFICANCE;

BIOINFORMATICS; DEREGULATION;

GENE EXPRESSION;

ALGORITHM; ARTICLE; BIOINFORMATICS; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; GENE EXPRESSION; GENE IDENTIFICATION; GENE REGULATORY NETWORK; HUMAN; PHENOTYPE; PRIORITY JOURNAL; REPRODUCIBILITY; STATISTICAL MODEL; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; HUMAN GENOME; METABOLISM; PROCEDURES;

COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENOME, HUMAN; GENOMICS; HUMANS; MODELS, STATISTICAL; REPRODUCIBILITY OF RESULTS;

EID: 77952743808     PISSN: 15320464     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbi.2009.09.005     Document Type: Article

References (63)

1. Golub T.R., Slonim D.K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J.P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286 (1999) 531-537
2. Vogelstein B., and Kinzler K.W. Cancer genes and the pathways they control. Nat Med 10 (2004) 789-799
3. Schena M., Shalon D., Davis R.W., and Brown P.O. Quantitative monitoring of gene-expression patterns with a complementary-DNA microarray. Science 270 (1995) 467-470
4. Manoli T., Gretz N., Grone H.J., Kenzelmann M., Eils R., and Brors B. Group testing for pathway analysis improves comparability of different microarray datasets. Bioinformatics 22 (2006) 25002506
5. Michiels S., Koscielny S., and Hill C. Predictor of cancer outcome with microarrays: a multiple random validation strategy. Lancet 365 (2005) 488-492
6. Allison D.B., Cui X., Page G.P., and Sabripour M. Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet 7 (2006) 55-65
7. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98 (2001) 5116-5121
8. Hsieh W.P., Chub T.M., Wolfinger R.D., and Gibson G. Mixed-model reanalysis of primate data suggests tissue and species biases in oligonucleotide-based gene expression profiles. Genetics 165 (2003) 747-757
9. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102 (2005) 15545-15550
10. Tian L., Greenberg S.A., Kong S.W., Altschuler J., Kohane I.S., and Park P.J. Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci USA 102 (2005) 13544-13549
11. Bild A.H., Yao G., Chang J.T., Wang Q., Potti A., et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439 (2006) 353-357
12. Creighton C.J. Multiple oncogeneic pathway signatures shows coordinate expression patterns in human prostate tumors. PLoS ONE 3 3 (2008) e1816
13. Maglietta R., Piepoli A., Catalano D., Licciulli F., Carella M., Liuni S., et al. Statistical assessment of functional categories of genes deregulated in pathological conditions by using microarray data. Bioinformatics 23 16 (2007) 20632072
14. Viswanathan G.A., Seto J., Patil S., Nudelman G., and Sealfon S.C. Getting started in biological pathway construction and analisys. PLoS Comput Biol 4 2 (2008) e16
15. Papoulis A. The Fourier integral and its applications (1962), McGraw-Hill
16. Girosi F., Jones M., and Poggio T. Regularization theory and neural networks architectures. Neural Comput 7 2 (1995) 219-269
17. Ancona N., Maglietta R., Piepoli A., D'Addabbo A., Cotugno R., Savino M., et al. On the statistical assessment of classifiers using DNA microarray data. BMC Bioinform 19 (2006) 7:387
18. Gardina P.J., Clark T.A., Shimada B., Staples M.K., Yang Q., Veitch J., et al. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics 7 (2006) 325
19. Jiang X., Tan J., Li J., Kivimäe S., et al. DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. Cancer Cell 13 6 (2008) 529-541
20. Newton M.A., Quintana F.A., Den Boon J.A., Sengupta S., and Ahlquist P. Random-set methods identify distinct aspects of the enrichment signal in gene-set analysis. Ann Appl Stat 1 1 (2007) 85106
21. Efron B., and Tibshirani R. On thesting the significance of sets of genes. Ann Appl Stat 1 1 (2007) 107129
22. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4 (2003) 249-264
23. Good P. Permutation tests: a practical guide to resampling methods for testing hypothesis (1994), Springer
24. Barry W.T., Nobel A.B., and Wright F.A. Significance analysis of functional categories in gene expression studies: a structured permutation approach. Bioinformatics 21 (2005) 1943-1949
25. Croonquist P.A., Linden M.A., Zhao F., and Van Ness B.G. Gene profiling of a myeloma cell line reveals similarities and unique signatures among il-6 response, n-ras-activating mutations, and coculture with bone marrow stromal cells. Blood 102 7 (2003) 2581-2592
26. Affar E.B., Gay F., Shi Y., Liu H., Huarte M., Wu S., et al. Essential dosage-dependent functions of the transcription factor yin yang 1 in late embryonic development and cell cycle progression. Mol Cell Biol 26 9 (2006) 3565-3581
27. Bild A.H., Yao G., Chang J.T., Wang Q., Potti A., Chasse D., et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439 7074 (2006) 353-357
28. Birkenkamp-Demtroder K., Christensen L.L., Olesen S.H., Frederiksen C.M., Laiho P., Aaltonen L.A., et al. Gene expression in colorectal cancer 1,2. Cancer Res 62 (2002) 4352-4363
29. Brentani H., Caballero O.L., Camargo A.A., da Silva A.M., Araujo da Silva Jr. W., Neto E.D., et al. The human cancer genome project/cancer genome anatomy project annotation consortium, and the human cancer genome project sequencing consortium, the generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. PNAS 100 23 (2003) 13418-13423
30. Burton G.R., Nagarajan R., Peterson C.A., and McGehee Jr. R.E. Microarray analysis of differentiation-specific gene expression during 3t3-l1 adipogenesis. Gene 329 (2004) 167-185
31. Chang H.Y., Sneddon J.B., Alizadeh A.A., Sood R., West R.B., Montgomery K., et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2 2 (2004) 206-214
32. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 1 (2000) 57-70
33. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
34. Goldrath A.W., Luckey C.J., Park R., Benoist C., and Mathis D. The molecular program induced in t cells undergoing homeostatic proliferation. Proc Natl Acad Sci USA 101 (2004) 16885-16890
35. Grabsch H., Dattani M., Barker L., Maughan N., Maude K., Hansen O., et al. Expression of dna double-strand break repair proteins atm and brca1 predicts survival in colorectal cancer. Clin Cancer Res 12 5 (2006) 1494-1500
36. Greco C., Alvino S., Buglioni S., Assisi D., Lapenta R., Grassi A., et al. Anticancer Res 21 5 (2001) 3185-3192
37. Han J., Xia C., Gao J., Xing C., Yang X., Tang X., et al. xpression of vascular endothelial growth factor in colorectal cancer and its clinical significance. Zhonghua Yi Xue Za Zhi 82 7 (2002) 481-483
38. Hershko D., Bornstein G., Ben-Izhak O., Carrano A., Pagano M., Krausz M.M., et al. Inverse relation between levels of p27(kip1) and of its ubiquitin ligase subunit skp2 in colorectal carcinomas. Cancer 91 (2001) 1745-1751
39. Iritani B.M., Delrow J., Grandori C., Gomez I., Klacking M., Carlos L.S., et al. growth and cell size by the myc antagonist and transcriptional repressor mad1. EMBO J 21 18 (2002) 4820-4830
40. Irizarry R.A., Zhijin W., and Harris A.J. Comparison of affymetrix genechip expression measures. Bioinformatics 22 (2006) 789-794
41. Kanehisa M., Araki M., Goto S., Hattori M., Hirakawa M., Itoh M., et al. Kegg for linking genomes to life and the environment. Nucleic Acids Res 36 (2008) D480-D484
42. Kang H.C., Kim I., Park J.H., Shin Y., Ku J.L., Jung M.S., et al. Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays. Clin Cancer Res 10 (2004) 272-284
43. Manalo D.J., Rowan A., Lavoie T., Natarajan L., Kelly B.D., Ye S.Q., et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by hif-1. Blood 105 2 (2005) 659-669
44. Mariadason J.M., Corner G.A., and Augenlicht L.H. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin a, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res 60 16 (2000) 4561-4572
45. Peart M.J., Smyth G.K., van Laar R.K., Bowtell D.D., Richon V.M., Marks P.A., et al. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. Proc Natl Acad Sci USA 102 10 (2005) 3697-3702
46. Morin P.J., Vogelstein B., and Kinzler K.W. Apoptosis and apc in colorectal tumorigenesis. Proc Natl Acad Sci USA 93 (1996) 7950-7954
47. Rhodes D.R., Yu J., Shanker K., Deshpande N., Varambally R., Ghosh D., et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 101 25 (2004) 9309-9314
48. Sansom O.J., Reed K.R., Hayes A.J., Ireland H., Brinkmann H., Newton I.P., et al. Loss of apc in vivo immediately perturbs wnt signaling, differentiation, and migration. Genes Dev 18 12 (2004) 1385-1390
49. Schernhammer E.S., Ogino S., and Fuchs C.S. Folate and vitamin b6 intake and risk of colon cancer in relation to p53 expression. Gastroenterology 135 (2008) 770-780
50. Schuhmacher M., Kohlhuber F., Hlzel M., Kaiser C., Burtscher H., Jarsch M., et al. The transcriptional program of a human b cell line in response to myc. Nucleic Acids Res 29 2 (2001) 397-406
51. Seidler H.B.K., Utsuyama M., Nagaoka S., Takemura T., Kitagawa M., and Hirokawa K. Expression level of wnt signaling components possibly influences the biological behavior of colorectal cancer in different age groups. Exp Mol Pathol 76 (2004) 224-233
52. Shepard J.L., Amatruda J.F., Stern H.M., Subramanian A., Finkelstein D., Ziai J., et al. A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility. Proc Natl Acad Sci USA 102 37 (2005) 13194-13199
53. Sherr C.J., and Roberts J.M. Cdk inhibitors: positive and negative regulators of g1-phase progression. Genes Dev 13 (1999) 1501-1512
54. Thangaraju M., Carswell K.N., Prasad P.D., and Ganapathy V. Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of hdac1/hdac3. Biochem J (2008)
55. Tsihlias J., Kapusta L., and Slingerland J. The prognostic significance of altered cyclin dependent kinase inhibitors in human cancer. Annu Rev Med 50 (1999) 401-423
56. Underhill G.H., George D., Bremer E.G., and Kansas G.S. Gene expression profiling reveals a highly specialized genetic program of plasma cells. Blood 101 10 (2003) 4013-4021
57. van't Veer L.J., Dai H H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 6871 (2002) 530-536
58. Vernell R., Helin K., and Muller H. Identification of target genes of the p16ink4a-prb-e2f pathway. J Biol Chem 278 46 (2003) 46124-46137
59. Vorburger S.A., Pataer A., Yoshida K., Liu Y., Lu X., Swisher S.G., et al. The mitochondrial apoptosis-inducing factor plays a role in e2f-1induced apoptosis in human colon cancer cells. Ann Surg Oncol 10 3 (2003) 314322
60. Wang G., Chuang L., Zhang X., Colton S., Dombkowski A., Reiners J., et al. The initiative role of xpc protein in cisplatin dna damaging treatment-mediated cell cycle regulation. Nucleic Acids Res 32 (2004) 2231-2240
61. White R.J. Rna polymerases i and iii, growth control and cancer. Nat Rev Mol Cell Biol 6 (2005) 67-69
62. Wu Q., Kirschmeier P., Hockenberry T., Yang T.Y., Brassard D.L., Wang L., et al. Transcriptional regulation during p21waf1/cip1-induced apoptosis in human ovarian cancer cells. J Biol Chem 277 39 (2002) 36329-36337
63. Zamora R., Vodovotz Y., Aulak K.S., Kim P.K., Kane J.M., Alarcon L., et al. A dna microarray study of nitric oxide-induced genes in mouse hepatocytes: implications for hepatic heme oxygenase-1 expression in ischemia/reperfusion. Nitric Oxide 7 3 (2002) 165-186